Each lot of this antibody is quality control tested by Western blotting. Western blotting, suggested working dilution(s): Use 10 μl per 5 ml antibody dilution buffer for each mini-gel. It is recommended that the reagent be titrated for optimal performance for each application.
Hela cell extract was resolved by electrophoresis, transferred to nitrocellulose and probed with rabbit anti-GSK 3ß antibody. Proteins were visualized using a donkey anti-rabbit secondary conjugated to HRP and a chemiluminescence detection system.
Recombinant human full length GSK3 beat containing an N-terminal GST tag protein (400 ng per lane) was resolved by electrophoresis, transferred to nitrocellulose and probed with rabbit anti-GSK 3ß antibody. Proteins were visualized using a donkey anti-rabbit secondary conjugated to HRP and a chemiluminescence detection system.
Description:
GSK-3β (glycogen synthase kinase-3 beta) is a 49 kD serine/threonine kinase that is a member of the CDC2/CDKX subfamily. This protein is expressed in the testis, thymus, prostate, and ovary, with weak expression in lung, brain, and kidney. GSK-3β is thought to participate in the insulin and Wnt signaling pathway and has been shown to phosphorylate c-jun to reduce DNA binding. GSK-3β can be modified by AKT phosphorylation which inhibits function. This protein has been shown to interact with axin and GBP/FRAT. The Poly6042 antibody recognizes human and mouse GSK-3β and is cross-reactive with GSK-3α. The Poly6042 antibody has been shown to be useful for Western blotting.
Other Names:
Glycogen synthase kinase-3 beta
Structure:
Serine/Threonine family protein kinases, CDC2/CDKX subfamily, monomer; 49 kD
Distribution:
Testis, thymus, prostate, ovary. Weak expression in lung, brain, kidney
Function:
Participates in insulin and Wnt signaling pathway, phosphorylates c-jun to reduce DNA binding
Regulation:
Inhibited by AKT phosphorylation
Modification:
Phosphorylation
Interaction:
Interacts with axin, GBP/FRAT
Antigen References:
1. Stambolic, V., et al., 1994. Biochem. J. 303:701. 2. Delcommenne, M, et al., 1998. PNAS 95:11211.
*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering/). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.
